{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T07:05:13.26386+00:00","published_at":"2026-10-17T04:46:39.768585+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:19ytrsf4e1sxl","event_type":"GC_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:carolyn-m-rucci","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:63f6fa7b27e8db43e9ff20758f00ebea297253e6c89ad4b4b6eb02e90d6a85da"],"summary":"Carolyn M. Rucci executive of Akebia Therapeutics, Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:144qgiz16muoq3","event_type":"CFO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:erik-j-ostrowski-akba","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:946acee5d083e6d383273f64f7250b57cc2b75080e0b922de0d49cdb138d872d"],"summary":"Erik J. Ostrowski executive of Akebia Therapeutics, Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1cswclmz7y4x0","event_type":"CEO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:john-p-butler-akba","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:ff80bae57d6bc02ca80e60bc6ae7b1f390d5c90493f6026c74b4019520e5587a"],"summary":"John P. Butler executive of Akebia Therapeutics, Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6ahtiys7ehwg","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:nicholas-p-grund-akba","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:69d555864cf0de64d2580883789826f0f983fb993e56b5ac7ab863a8e2bf04b0"],"summary":"Nicholas P. Grund executive of Akebia Therapeutics, Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2agq3d1npkmbl","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:steven-k-burke-akba","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:a36a08428bd41c3a3ce3d486eaf0e636b9da777b3d6c3dd3d12ac08bd648ffc1"],"summary":"Steven K. Burke executive of Akebia Therapeutics, Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7wipeegcsuiu","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:leanne-m-zumwalt","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"LeAnne M. Zumwalt seat on Akebia Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19yfak2yyyrti","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:ronald-e-frieson","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Ronald E. Frieson seat on Akebia Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wxvwlcebl5re","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:committee:akebia-therapeutics-inc:audit-nominating-and-governance","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Audit; Nominating and Governance committee of Akebia Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ylhb6cr0e6ja","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:leanne-m-zumwalt","alpha:committee:akebia-therapeutics-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"LeAnne M. Zumwalt member of Audit; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1sbkjz8u42lqy","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:committee:akebia-therapeutics-inc:audit-nominating-and-governance-chair","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Audit; Nominating and Governance · Chair committee of Akebia Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1f8750y1oow25y","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:ronald-e-frieson","alpha:committee:akebia-therapeutics-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Ronald E. Frieson member of Audit; Nominating and Governance · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14l5mfoytjdr6","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:myles-wolf-m-d-m-m-sc","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Myles Wolf, M.D., M.M.Sc. seat on Akebia Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14660d1xow46p","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:adrian-adams","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Adrian Adams seat on Akebia Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nk7qcz7y3hq","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Cynthia Smith seat on Akebia Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6j6vqph30g5x","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:michael-rogers","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Michael Rogers seat on Akebia Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1sc14efjv9xkn","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:steven-c-gilman-ph-d","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Steven C. Gilman, Ph.D. seat on Akebia Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7hs7elzh2wct","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:committee:akebia-therapeutics-inc:audit-chair","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Audit · Chair committee of Akebia Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:drfu9rhlk2ff","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:michael-rogers","alpha:committee:akebia-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Michael Rogers member of Audit · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1c8ouufu6a8aj","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:adrian-adams","alpha:committee:akebia-therapeutics-inc:compensation"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_record:22"],"evidence_ids":["alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2"],"summary":"Adrian Adams member of Compensation, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ids6di1a109ky","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:committee:akebia-therapeutics-inc:compensation-chair","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Compensation · Chair committee of Akebia Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1umuubb1938upt","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:committee:akebia-therapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"Cynthia Smith member of Compensation · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:5spyhg1a01hqg","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-17T04:46:39.768585+00:00","subject_ids":["alpha:person:john-p-butler","alpha:company:bad017fc-48c8-414b-909d-59a159d476d0"],"caused_claim_ids":["alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9"],"summary":"John P. Butler seat on Akebia Therapeutics, Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:5","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:adrian-adams","object_label":"Adrian Adams","object_source_name_forms":[],"value":"Adrian Adams: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:adrian-adams","name":"Adrian Adams"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:6","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:cynthia-smith","object_label":"Cynthia Smith","object_source_name_forms":[],"value":"Cynthia Smith: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:7","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-p-butler","object_label":"John P. Butler","object_source_name_forms":[],"value":"John P. Butler: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-p-butler","name":"John P. Butler"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:8","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:leanne-m-zumwalt","object_label":"LeAnne M. Zumwalt","object_source_name_forms":[],"value":"LeAnne M. Zumwalt: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:leanne-m-zumwalt","name":"LeAnne M. Zumwalt"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:9","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-rogers","object_label":"Michael Rogers","object_source_name_forms":[],"value":"Michael Rogers: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-rogers","name":"Michael Rogers"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:10","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:myles-wolf-m-d-m-m-sc","object_label":"Myles Wolf, M.D., M.M.Sc.","object_source_name_forms":[],"value":"Myles Wolf, M.D., M.M.Sc.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:myles-wolf-m-d-m-m-sc","name":"Myles Wolf, M.D., M.M.Sc."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:11","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ronald-e-frieson","object_label":"Ronald E. Frieson","object_source_name_forms":[],"value":"Ronald E. Frieson: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ronald-e-frieson","name":"Ronald E. Frieson"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:12","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-c-gilman-ph-d","object_label":"Steven C. Gilman, Ph.D.","object_source_name_forms":[],"value":"Steven C. Gilman, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-c-gilman-ph-d","name":"Steven C. Gilman, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:13","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:carolyn-m-rucci","object_label":"Carolyn M. Rucci","object_source_name_forms":[],"value":"Carolyn M. Rucci: Senior Vice President, Chief Legal Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:carolyn-m-rucci","name":"Carolyn M. Rucci"},"title":"Senior Vice President, Chief Legal Officer and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:63f6fa7b27e8db43e9ff20758f00ebea297253e6c89ad4b4b6eb02e90d6a85da","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:59.605809+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:14","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:erik-j-ostrowski-akba","object_label":"Erik J. Ostrowski","object_source_name_forms":[],"value":"Erik J. Ostrowski: Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:erik-j-ostrowski-akba","name":"Erik J. Ostrowski"},"title":"Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:946acee5d083e6d383273f64f7250b57cc2b75080e0b922de0d49cdb138d872d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:58.020474+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:15","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-p-butler-akba","object_label":"John P. Butler","object_source_name_forms":[],"value":"John P. Butler: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-p-butler-akba","name":"John P. Butler"},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:ff80bae57d6bc02ca80e60bc6ae7b1f390d5c90493f6026c74b4019520e5587a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:57.467992+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:16","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:nicholas-p-grund-akba","object_label":"Nicholas P. Grund","object_source_name_forms":[],"value":"Nicholas P. Grund: Senior Vice President, Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:nicholas-p-grund-akba","name":"Nicholas P. Grund"},"title":"Senior Vice President, Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:69d555864cf0de64d2580883789826f0f983fb993e56b5ac7ab863a8e2bf04b0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:59.05191+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:17","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:steven-k-burke-akba","object_label":"Steven K. Burke","object_source_name_forms":[],"value":"Steven K. Burke: Senior Vice President, Chief Research Development and Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:steven-k-burke-akba","name":"Steven K. Burke"},"title":"Senior Vice President, Chief Research Development and Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:document:a36a08428bd41c3a3ce3d486eaf0e636b9da777b3d6c3dd3d12ac08bd648ffc1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:58.535546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_record:22","subject_id":"alpha:company:bad017fc-48c8-414b-909d-59a159d476d0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Cynthia Smith; Members Cynthia Smith (Chair); Adrian Adams","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Cynthia Smith","members":[{"display_name":"Cynthia Smith","person_slug":"cynthia-smith","is_chair":true},{"display_name":"Adrian Adams","person_slug":"adrian-adams","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:39.768585+00:00","sources":[{"id":"alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Akebia Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:18:00.952+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:63f6fa7b27e8db43e9ff20758f00ebea297253e6c89ad4b4b6eb02e90d6a85da","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:59.605809+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:946acee5d083e6d383273f64f7250b57cc2b75080e0b922de0d49cdb138d872d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:58.020474+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ff80bae57d6bc02ca80e60bc6ae7b1f390d5c90493f6026c74b4019520e5587a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:57.467992+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:69d555864cf0de64d2580883789826f0f983fb993e56b5ac7ab863a8e2bf04b0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:59.05191+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a36a08428bd41c3a3ce3d486eaf0e636b9da777b3d6c3dd3d12ac08bd648ffc1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AKBA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-14T23:16:58.535546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.843,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.65},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:39.768585+00:00","observed_at":"2026-10-17T04:46:39.768585+00:00","reviewed_at":"2026-10-17T04:46:39.768585+00:00","verified_at":"2026-10-17T04:46:39.768585+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/akebia-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}